UK women warned of ongoing hormone replacement treatment shortages

Shortages of HRT products like Estradot and FemSeven Conti patches could last for weeks, with some access limited until January 2027.

UK women warned of ongoing hormone replacement treatment shortages
Photo: Metro

Women in the UK have been warned that shortages of Hormone Replacement Treatment (HRT) could continue for weeks. The Department of Health and Social Care revealed that several HRT products are currently out of stock. Two major patch brands, Estradot and FemSeven Conti, are experiencing the most disruption.

Pharmacies expect FemSeven Conti patches to return to shelves by the end of November, but access to Estradot is expected to remain limited until January 2027. To minimise the impact, the Department of Health has approved Estradot for serious shortage protocols (SSPs). These emergency regulatory measures allow pharmacists to supply specified alternative medicines without contacting the original prescriber.

Around two million women in England aged 40 and above regularly rely on HRT to manage menopause symptoms. The treatment replaces or tops up falling levels of hormones, primarily oestrogen and progesterone, to manage symptoms such as hot flashes, night sweats, brain fog, mood swings, anxiety, and vaginal dryness.

Dr Louise Newson, a physician and hormone specialist, said the Estradot shortage is worrying because hormones are an essential treatment to help ease symptoms and protect long-term health. She stated that manufacturers and the government need to work together on a lasting solution so no woman has to ring pharmacies to find her medicine.

Supply chain disruption driven by surging consumer demand has been an issue since 2024. Experts have urged the government to address the disruption before women seek alternative solutions that could put their health at risk.

Key facts

  • Estradot patch access is expected to remain limited until January 2027.
  • FemSeven Conti patches are expected back on shelves by the end of November.
  • The Department of Health has placed Estradot under serious shortage protocols.
  • Approximately two million women in England aged 40 and above rely on HRT.

Three perspectives

Neutral

The Department of Health and Social Care has confirmed shortages of certain HRT products, including Estradot and FemSeven Conti patches.

Positive

The Department of Health has approved serious shortage protocols for Estradot to allow pharmacists to supply alternative medicines without contacting prescribers.

Negative

Access to Estradot patches is expected to remain limited until January 2027.

Your week in news, every Wednesday

The biggest stories of the week for your edition, in your inbox every Wednesday morning, your time. Free, and you can unsubscribe at any time.

Choose your news coverage

Please choose and confirm your coverage.

Next storyNHS staff inappropriately accessed patient records over 3,000 times

All sections

Edition